contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
      researchContentUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


revenio-group-corporations-financial-reporting-and-annual-general-meeting-in-2023

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Revenio is a global provider of comprehensive eye care diagnostic solutions. The group offers fast, user-friendly, and reliable tools for diagnosing glaucoma, diabetic retinopathy, and macular degeneration (AMD). Revenio’s ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as software solutions under the iCare brand.

In 2023, the Group’s net sales totaled EUR 96.6 million, with an operating profit of EUR 26.3 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.

Well, now it’s high time to jump ship. Getinge, Volati, and Revenio all seem to have gotten undeserved appreciation during the corona turmoil and haven’t done anything for years. However, all of them have a similar nice profile; “you’ll never get these at a P/E of ten”. I guess one of these three will succeed, hopefully Revenio

Bråsen’s predictions were pretty accurate when he worked as an analyst for DI. Four other companies might also be worth looking into. Swedes could put on their buying pants and start stocking up on Revenio.

In Revenio, Bråse sees  a severely depressed valuation accelerating growth  The picks from this fund manager with “clear” upside potential are Getinge, Volati, Eastnine, Revenio, and Electrolux Professional. Fingers crossed for these insights…  Revenio is highlighted for its heavily suppressed valuation despite accelerating growth   Richard Bråse picks five stocks with clear upside for Dagens industri: Getinge, Volati, Eastnine, Revenio, and Electrolux Professional.  Bråse’s five favorite stocks - sees buying opportunity in distressed stocks - Di | Placera.se Bråses fem favoritaktier - ser fyndläge i pressade aktier - Di | Placera.se

Spotted on Nordnet, nothing new or amazing, but perhaps people will wake up a bit regarding Revenio:

This is a pretty convincing picture. Halfway to becoming a Dividend Aristocrat. Are the years when the dividend remained the same counted, or only the years when the dividend increased? Well, they certainly grow. But what about extra dividends?

However, this point is interesting: 20. Amendment of Article 4 of the Articles of Association The Board of Directors proposes that Article 4 of the Articles of Association be amended such that the maximum number of ordinary members of the Board of Directors changes from seven (7) to eight (8),… So, more room, even if all seats are not filled. Does this indicate an upcoming deal, where representatives of the acquired company will have a place on the board?

Revenio Group              Revenio Group Oyj: Yhtiökokouskutsu 2026                              The notice of the Annual General Meeting (AGM) has now been issued. The AGM will be held on April 15, 2026. The Board of Directors is proposed to have 5 members, compared to 7 last year. Pekka Tammela and Ann-Christine Sundell would step down. Proposal for profit distribution: “The Board proposes that the Annual General Meeting authorize the Board of Directors to decide, at its discretion, on the payment of a dividend, of a maximum of 0.44 euros per share, by December 31, 2026. The dividend may be distributed in one or several installments. Based on the authorization granted to the Board, the Board shall determine the dividend record date and payment date when deciding on the dividend payment.” In previous years, it was paid at the end of April.

Revenio Group

Revenio Group Corporation, Stock exchange release, October 27, 2022 at 9.15 a.m. (EEST)Revenio Group Corporation’s financial reporting and Annual General Meeting in 2023Revenio Group Corporation...

<div class="mfn-preamble">Revenio Group Corporation, Stock exchange release, October 27, 2022 at 9.15 a.m. (EEST)</div><div class="mfn-body">Revenio Group Corporation’s financial reporting and Annual General Meeting in 2023Revenio Group Corporation will publish the following financial reports during 2023:<ul><li>Financial Statements Bulletin for the year 2022 on Thursday, February 9, 2023</li><li>Annual reporting package 2022 during week 9 in 2023</li><li>Interim report 1-3/2023 on Thursday, April 27, 2023</li><li>Half-year financial report 1-6/2023 on Thursday, August 10, 2023</li><li>Interim report 1-9/2023 on Thursday, October 26, 2023</li></ul>The financial statements bulletin, half-year report and interim reports will be published at approximately 9.00 am Finnish time on the above dates. The Annual General Meeting is planned to be held on Thursday, March 23, 2023. The Board of Directors of the company will convene the meeting.A shareholder, who wishes to include an item on the agenda of the Annual General Meeting, shall submit the request in writing to the company's Board of Directors by February 3, 2023. Such requests including the reasoning, or a resolution proposal can be submitted to the address: Revenio Group Corporation / Board of Directors, Äyritie 22, FI-01510 Vantaa, Finland.For further information, please contact Robin Pulkkinen, CFO, tel. +358 50&nbsp;505 9932 <a rel="nofollow noopener" href="mailto:robin.pulkkinen@revenio.fi">robin.pulkkinen@revenio.fi</a>Distribution Nasdaq Helsinki Key media <a rel="nofollow noopener" href="http://www.revenio.fi">www.revenio.fi</a>Revenio Group in brief Revenio is a leading company in the global market for ophthalmological devices and software solutions. Revenio’s ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as clinical software under the iCare brand. iCare is a trusted partner in ophthalmic diagnostics, offering physicians fast, easy-to-use, and reliable tools for the diagnosis of glaucoma, diabetic retinopathy, and macular degeneration (AMD). iCare Solutions provide digital clinical tools that drive greater efficiency and enhance quality in eye care.In 2021, the Group’s net sales totaled EUR 78.8 million, with an operating profit of EUR 22.1 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.</div><div class="mfn-footer mfn-attachment mfn-attachment-general">Attachments<hr><a rel="nofollow noopener" href="https://storage.mfn.se/114a0b42-d6c4-4db2-bfc7-f35f8955dacc/revenio-group-corporations-financial-reporting-and-annual-general-meeting-in-2023.pdf" class="mfn-generated mfn-primary">Revenio Group Corporation’s financial reporting and Annual General Meeting in 2023</a></div>